AJP - Endo Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 280: E150-E159, 2001;
0193-1849/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (31)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gordon, S. E.
Right arrow Articles by Booth, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gordon, S. E.
Right arrow Articles by Booth, F. W.
Vol. 280, Issue 1, E150-E159, January 2001

ANG II is required for optimal overload-induced skeletal muscle hypertrophy

Scott E. Gordon1,2, Bradley S. Davis1,2, Christian J. Carlson1,2, and Frank W. Booth1,2

1 Department of Integrative Biology and Pharmacology, University of Texas - Houston Health Science Center, Houston, Texas 77030; and 2 Department of Veterinary Biomedical Sciences, University of Missouri, Columbia, Missouri 65211

ANG II mediates the hypertrophic response of overloaded cardiac muscle, likely via the ANG II type 1 (AT1) receptor. To examine the potential role of ANG II in overload-induced skeletal muscle hypertrophy, plantaris and/or soleus muscle overload was produced in female Sprague-Dawley rats (225-250 g) by the bilateral surgical ablation of either the synergistic gastrocnemius muscle (experiment 1) or both the gastrocnemius and plantaris muscles (experiment 2). In experiment 1 (n = 10/ group), inhibiting endogenous ANG II production by oral administration of an angiotensin-converting enzyme (ACE) inhibitor during a 28-day overloading protocol attenuated plantaris and soleus muscle hypertrophy by 57 and 96%, respectively (as measured by total muscle protein content). ACE inhibition had no effect on nonoverloaded (sham-operated) muscles. With the use of new animals (experiment 2; n = 8/group), locally perfusing overloaded soleus muscles with exogenous ANG II (via osmotic pump) rescued the lost hypertrophic response in ACE-inhibited animals by 71%. Furthermore, orally administering an AT1 receptor antagonist instead of an ACE inhibitor produced a 48% attenuation of overload-induced hypertrophy that could not be rescued by ANG II perfusion. Thus ANG II may be necessary for optimal overload-induced skeletal muscle hypertrophy, acting at least in part via an AT1 receptor-dependent pathway.

angiotensin-converting enzyme; angiotensin II type 1 receptor; compensatory hypertrophy; loading; mechanical stress


This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
M. Miyazaki and K. A. Esser
Cellular mechanisms regulating protein synthesis and skeletal muscle hypertrophy in animals
J Appl Physiol, April 1, 2009; 106(4): 1367 - 1373.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
T. McCauley, S. S. Mastana, J. Hossack, M. MacDonald, and J. P. Folland
Human angiotensin-converting enzyme I/D and {alpha}-actinin 3 R577X genotypes and muscle functional and contractile properties
Exp Physiol, January 1, 2009; 94(1): 81 - 89.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. Yamin, O. Amir, M. Sagiv, E. Attias, Y. Meckel, N. Eynon, M. Sagiv, and R. E. Amir
ACE ID genotype affects blood creatine kinase response to eccentric exercise
J Appl Physiol, December 1, 2007; 103(6): 2057 - 2061.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
O. Amir, R. Amir, C. Yamin, E. Attias, N. Eynon, M. Sagiv, M. Sagiv, and Y. Meckel
Human, Environmental & Exercise: The ACE deletion allele is associated with Israeli elite endurance athletes
Exp Physiol, September 1, 2007; 92(5): 881 - 886.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. M. Thomson and S. E. Gordon
Impaired overload-induced muscle growth is associated with diminished translational signalling in aged rat fast-twitch skeletal muscle
J. Physiol., July 1, 2006; 574(1): 291 - 305.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. M. Westerkamp and S. E. Gordon
Angiotensin-converting enzyme inhibition attenuates myonuclear addition in overloaded slow-twitch skeletal muscle
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R1223 - R1231.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. B. Kritchevsky, B. J. Nicklas, M. Visser, E. M. Simonsick, A. B. Newman, T. B. Harris, E. M. Lange, B. W. Penninx, B. H. Goodpaster, S. Satterfield, et al.
Angiotensin-Converting Enzyme Insertion/Deletion Genotype, Exercise, and Physical Decline
JAMA, August 10, 2005; 294(6): 691 - 698.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
T. Y. Kostrominova, D. E. Dow, R. G. Dennis, R. A. Miller, and J. A. Faulkner
Comparison of gene expression of 2-mo denervated, 2-mo stimulated-denervated, and control rat skeletal muscles
Physiol Genomics, July 14, 2005; 22(2): 227 - 243.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. M. Thomson and S. E. Gordon
Diminished overload-induced hypertrophy in aged fast-twitch skeletal muscle is associated with AMPK hyperphosphorylation
J Appl Physiol, February 1, 2005; 98(2): 557 - 564.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. S. Hopkinson, A. H. Nickol, J. Payne, E. Hawe, W. D.-C. Man, J. Moxham, H. Montgomery, and M. I. Polkey
Angiotensin Converting Enzyme Genotype and Strength in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 395 - 399.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. G. Williams, S. S. Dhamrait, P. T. E. Wootton, S. H. Day, E. Hawe, J. R. Payne, S. G. Myerson, M. World, R. Budgett, S. E. Humphries, et al.
Bradykinin receptor gene variant and human physical performance
J Appl Physiol, March 1, 2004; 96(3): 938 - 942.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. Bahi, N. Koulmann, H. Sanchez, I. Momken, V. Veksler, A. X. Bigard, and R. Ventura-Clapier
Does ACE inhibition enhance endurance performance and muscle energy metabolism in rats?
J Appl Physiol, January 1, 2004; 96(1): 59 - 64.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. E. Childs, E. E. Spangenburg, D. R. Vyas, and F. W. Booth
Temporal alterations in protein signaling cascades during recovery from muscle atrophy
Am J Physiol Cell Physiol, August 1, 2003; 285(2): C391 - C398.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. G. Williams, S. H. Day, S. Dhamrait ;, and R. M. Fuentes
ACE gene, physical activity, and physical fitness
J Appl Physiol, October 1, 2002; 93(4): 1561 - 1562.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Hlaing, X. Shen, P. Dazin, and H. S. Bernstein
The Hypertrophic Response in C2C12 Myoblasts Recruits the G1 Cell Cycle Machinery
J. Biol. Chem., June 21, 2002; 277(26): 23794 - 23799.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. W. Smith, J. D. Smith, and D. S. Criswell
Involvement of nitric oxide synthase in skeletal muscle adaptation to chronic overload
J Appl Physiol, May 1, 2002; 92(5): 2005 - 2011.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online